IL-17A and TNF-α as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19
Copyright © 2020. Published by Elsevier Ltd..
Coronavirus disease 2019 (COVID-19) was declared a pandemic and international health emergency by the World Health Organization. Patients with obesity with COVID-19 are 7 times more likely to need invasive mechanical ventilation than are patients without obesity (OR 7.36; 95% CI: 1.63-33.14, p = 0.021). Acute respiratory distress syndrome (ARDS) is one of the main causes of death related to COVID-19 and is triggered by a cytokine storm that damages the respiratory epithelium. Interleukins that cause the chronic low-grade inflammatory state of obesity, such as interleukin (IL)-1β, IL-6, monocyte chemoattractant peptide (MCP)-1, and, in particular, IL-17A and tumour necrosis factor alpha (TNF-α), also play very important roles in lung damage in ARDS. Therefore, obesity is associated with an immune state favourable to a cytokine storm. Our hypothesis is that serum concentrations of TNF-α and IL-17A are more elevated in patients with obesity and COVID-19, and consequently, they have a greater probability of developing ARDS and death. The immunobiology of IL-17A and TNF-α opens a new fascinating field of research for COVID-19.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:144 |
---|---|
Enthalten in: |
Medical hypotheses - 144(2020) vom: 05. Nov., Seite 109935 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Leija-Martínez, José J [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 04.12.2020 Date Revised 10.01.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.mehy.2020.109935 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM313704961 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM313704961 | ||
003 | DE-627 | ||
005 | 20231225151138.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.mehy.2020.109935 |2 doi | |
028 | 5 | 2 | |a pubmed24n1045.xml |
035 | |a (DE-627)NLM313704961 | ||
035 | |a (NLM)32795834 | ||
035 | |a (PII)S0306-9877(20)31324-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Leija-Martínez, José J |e verfasserin |4 aut | |
245 | 1 | 0 | |a IL-17A and TNF-α as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19 |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.12.2020 | ||
500 | |a Date Revised 10.01.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020. Published by Elsevier Ltd. | ||
520 | |a Coronavirus disease 2019 (COVID-19) was declared a pandemic and international health emergency by the World Health Organization. Patients with obesity with COVID-19 are 7 times more likely to need invasive mechanical ventilation than are patients without obesity (OR 7.36; 95% CI: 1.63-33.14, p = 0.021). Acute respiratory distress syndrome (ARDS) is one of the main causes of death related to COVID-19 and is triggered by a cytokine storm that damages the respiratory epithelium. Interleukins that cause the chronic low-grade inflammatory state of obesity, such as interleukin (IL)-1β, IL-6, monocyte chemoattractant peptide (MCP)-1, and, in particular, IL-17A and tumour necrosis factor alpha (TNF-α), also play very important roles in lung damage in ARDS. Therefore, obesity is associated with an immune state favourable to a cytokine storm. Our hypothesis is that serum concentrations of TNF-α and IL-17A are more elevated in patients with obesity and COVID-19, and consequently, they have a greater probability of developing ARDS and death. The immunobiology of IL-17A and TNF-α opens a new fascinating field of research for COVID-19 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Acute respiratory distress syndrome | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a IL-17A | |
650 | 4 | |a Mortality | |
650 | 4 | |a Obesity | |
650 | 4 | |a Tumour necrosis factor-alpha | |
650 | 7 | |a Biomarkers |2 NLM | |
650 | 7 | |a IL17A protein, human |2 NLM | |
650 | 7 | |a Interleukin-17 |2 NLM | |
650 | 7 | |a TNF protein, human |2 NLM | |
650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
700 | 1 | |a Huang, Fengyang |e verfasserin |4 aut | |
700 | 1 | |a Del-Río-Navarro, Blanca E |e verfasserin |4 aut | |
700 | 1 | |a Sanchéz-Muñoz, Fausto |e verfasserin |4 aut | |
700 | 1 | |a Muñoz-Hernández, Onofre |e verfasserin |4 aut | |
700 | 1 | |a Giacoman-Martínez, Abraham |e verfasserin |4 aut | |
700 | 1 | |a Hall-Mondragon, Margareth S |e verfasserin |4 aut | |
700 | 1 | |a Espinosa-Velazquez, Dario |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Medical hypotheses |d 1983 |g 144(2020) vom: 05. Nov., Seite 109935 |w (DE-627)NLM00007487X |x 1532-2777 |7 nnns |
773 | 1 | 8 | |g volume:144 |g year:2020 |g day:05 |g month:11 |g pages:109935 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.mehy.2020.109935 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 144 |j 2020 |b 05 |c 11 |h 109935 |